blocking antibody

Related Overviews


'blocking antibody' can also refer to...

blocking antibody

blocking antibody

Effects of Angiopoietin-2-Blocking Antibody on Endothelial Cell–Cell Junctions and Lung Metastasis

Structure activity relationships of monocyte chemoattractant proteins in complex with a blocking antibody

Immunology: Diversity of the blocking effects of antisperm antibodies on fertilization in human and mouse

Blocking effects of serum reactive antibodies induced by glatiramer acetate treatment in multiple sclerosis

Subacute nodopathy with conduction blocks and anti-neurofascin 140/186 antibodies: an ultrastructural study

Properties of Blocking and Non-blocking Monoclonal Antibodies Specific for Human Macrophage Galactose-type C-type Lectin (MGL/ClecSF10A/CD301)

Anti–MSP1 Block 2 Antibodies Are Effective at Parasite Killing in an Allele-Specific Manner by Monocyte-Mediated Antibody-Dependent Cellular Inhibition

Ig L-chain Shuffling for Affinity Maturation of Phage Library-derived Human Anti-human MCP-1 Antibody Blocking its Chemotactic Activity

Antibodies against PsrP, a Novel Streptococcus pneumoniae Adhesin, Block Adhesion and Protect Mice against Pneumococcal Challenge

Human Anti–Human IL-18 Antibody Recognizing the IL-18–Binding Site 3 with IL-18 Signaling Blocking Activity

An Anti-Chitinase Malaria Transmission–Blocking Single-Chain Antibody as an Effector Molecule for Creating a Plasmodium falciparum–Refractory Mosquito

High Serum Levels of Norovirus Genotype–Specific Blocking Antibodies Correlate With Protection From Infection in Children

Human anti‐β‐amyloid antibodies block β‐amyloid fibril formation and prevent β‐amyloid‐induced neurotoxicity

Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro


Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis

P-382GC1118, an anti-EGFR monoclonal antibody, blocks irinotecan-induced EGFR activation and exhibits synergistic tumor regression in gastric cancer model


More Like This

Show all results sharing these subjects:

  • Chemistry
  • Medicine and Health


Show Summary Details

Quick Reference

An antibody used to prevent some other reaction taking place by physically masking a binding site, e.g. on a cell surface receptor.

Subjects: Chemistry — Medicine and Health.

Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content. subscribe or login to access all content.